IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
ZyVersa Therapeutics (Larkspur Health Acquisition) Priced, Nasdaq: ZVSA
Blank check company focused on the US biotechnology sector (completed 12/12/2022).
Industry: SPAC
Latest Trade: $5.45 0.00 (0.0%)
First Day Return: -0.2%
Return from IPO: -45.5%
Industry: SPAC
We are a newly-organized blank check company incorporated in Delaware. While our efforts to identify a target business may span many industries and regions worldwide, we intend to focus our search for prospects within the biotechnology sector in the United States. Our management team is led by Daniel O’Connor, our Chairman and CEO, and David Briones, our CFO and Secretary. Daniel O’Connor is founder and the manager of our sponsor, Larkspur Health.
| IPO Data | |
|---|---|
| IPO File Date | 05/13/2021 |
| Offer Price | $10.00 |
| Price Range $10.00 - $10.00 | |
| Offer Shares (mm) | 7.5 |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 12/20/2021 |
| Offer Price | $10.00 |
| Price Range $10.00 - $10.00 | |
| Offer Shares (mm) | 7.5 |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| Underwriters |
|---|
| A.G.P. |
| Brookline Capital Markets |
| Company Data | |
|---|---|
| Headquarters | Bridgewater, NJ, United States |
| Founded | 2021 |
| Employees | 2 |
IPO News for ZyVersa Therapeutics (Larkspur Health Acquisition)
ZyVersa Therapeutics (Larkspur Health Acquisition) (ZVSA) Performance
